Amgen touts positive results with new heart health drug
By Erika Martin / Friday, March 20th, 2015 / East Ventura County, Health Care & Life Science, Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen touts positive results with new heart health drug
If approved, it will be the Thousand Oaks-based biotech giant’s first new drug on the market since the FDA’s landmark approval of the first-ever biosimilar drug on the American market.

FarmSolutions gives growers tools to monitor crops
By Marissa Wenzke / Friday, March 20th, 2015 / Agribusiness, East Ventura County, Latest news, Small Business, Subscriber content, Technology, Top Stories / Comments Off on FarmSolutions gives growers tools to monitor crops

With California in the midst of some of its driest months on record, the statewide drought is far from over, and one Westlake Village firm is looking to bring farmers some solutions.
Tri-county public company ranks shrink as Vitesse sells for $389M
By Staff Report / Wednesday, March 18th, 2015 / Latest news, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies, West Ventura County / Comments Off on Tri-county public company ranks shrink as Vitesse sells for $389M
The deal values Vitesse at $5.28 per share, a premium of 32 percent over the stock’s 30-day average closing price.
Amgen braces for battle over biosimilars
By Erika Martin / Friday, March 13th, 2015 / East Ventura County, Latest news, Technology, Top Stories / Comments Off on Amgen braces for battle over biosimilars
On March 9, a company memo announced its plans to shutter San Francisco facilities once belonging to Onyx Pharmaceuticals and lay off 300 employees there.
FCC turns its sights to Comcast-Time Warner Cable deal
By Erika Martin / Friday, March 13th, 2015 / Latest news, Technology, Top Stories / Comments Off on FCC turns its sights to Comcast-Time Warner Cable deal
If approved — an outcome analysts feel is likely — the merger would create a Comcast-Cox duopoloy among tri-county cable providers.
Region wins as Amgen shuffles jobs
By Staff Report / Tuesday, March 10th, 2015 / Latest news, Technology, Top Stories / Comments Off on Region wins as Amgen shuffles jobs
In a company memo circulated yesterday, Amgen CEO Robert Bradway said the firm will begin reconsolidating oncology operations into its Thousand Oaks headquarters.
Amgen’s portfolio threatened as FDA paves path for lower-cost drugs
By Staff Report / Friday, March 6th, 2015 / Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen’s portfolio threatened as FDA paves path for lower-cost drugs

Zarxio, the first biopharmaceutical copycat approved in the U.S., will pave the way for lower-cost alternatives to existing treatments.